dihydroethidium has been researched along with oxidopamine in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (oxidopamine) | Trials (oxidopamine) | Recent Studies (post-2010) (oxidopamine) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 8,630 | 6 | 2,407 |
| Protein | Taxonomy | dihydroethidium (IC50) | oxidopamine (IC50) |
|---|---|---|---|
| Glyceraldehyde-3-phosphate dehydrogenase | Homo sapiens (human) | 8 | |
| DNA repair protein RAD52 homolog | Homo sapiens (human) | 0.779 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guerra, MJ; Joglar, B; Labandeira-Garcia, JL; Parga, JA; Rodriguez-Pallares, J | 1 |
1 other study(ies) available for dihydroethidium and oxidopamine
| Article | Year |
|---|---|
The mitochondrial ATP-sensitive potassium channel blocker 5-hydroxydecanoate inhibits toxicity of 6-hydroxydopamine on dopaminergic neurons.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Antihypertensive Agents; Benzimidazoles; Carbocyanines; Cell Count; Cells, Cultured; Decanoic Acids; Diazoxide; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Embryo, Mammalian; Ethidium; Glyburide; Hydroxy Acids; Membrane Potential, Mitochondrial; Mesencephalon; Neurons; Oxidopamine; Potassium Channel Blockers; Potassium Channels; Rats; Reactive Oxygen Species; Rhodamines; Time Factors; Tritium; Tyrosine 3-Monooxygenase | 2009 |